129 related articles for article (PubMed ID: 8104041)
1. Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic-free.
Nofzinger EA; van Kammen DP; Gilbertson MW; Gurklis JA; Peters JL
Biol Psychiatry; 1993 Jun 1-15; 33(11-12):829-35. PubMed ID: 8104041
[TBL] [Abstract][Full Text] [Related]
2. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia.
Taylor SF; Tandon R; Shipley JE; Eiser AS
Biol Psychiatry; 1991 Nov; 30(9):904-12. PubMed ID: 1684117
[TBL] [Abstract][Full Text] [Related]
3. Sleep in schizophrenic patients on and off haloperidol therapy. Clinically stable vs relapsed patients.
Neylan TC; van Kammen DP; Kelley ME; Peters JL
Arch Gen Psychiatry; 1992 Aug; 49(8):643-9. PubMed ID: 1637254
[TBL] [Abstract][Full Text] [Related]
4. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
[TBL] [Abstract][Full Text] [Related]
5. Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment.
Tandon R; Shipley JE; Taylor S; Greden JF; Eiser A; DeQuardo J; Goodson J
Arch Gen Psychiatry; 1992 Mar; 49(3):185-94. PubMed ID: 1348923
[TBL] [Abstract][Full Text] [Related]
6. Pupillary constriction during haloperidol treatment as a predictor of relapse following drug withdrawal in schizophrenic patients.
Steinhauer SR; van Kammen DP; Colbert K; Peters JL; Zubin J
Psychiatry Res; 1992 Sep; 43(3):287-98. PubMed ID: 1438625
[TBL] [Abstract][Full Text] [Related]
7. Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension.
Maixner S; Tandon R; Eiser A; Taylor S; DeQuardo JR; Shipley J
Am J Psychiatry; 1998 Nov; 155(11):1600-2. PubMed ID: 9812125
[TBL] [Abstract][Full Text] [Related]
8. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.
Wetter TC; Lauer CJ; Gillich G; Pollmächer T
J Psychiatr Res; 1996; 30(6):411-9. PubMed ID: 9023785
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of EEG sleep in schizophrenia.
Keshavan MS; Reynolds CF; Miewald JM; Montrose DM
Psychiatry Res; 1996 Jan; 59(3):203-11. PubMed ID: 8930026
[TBL] [Abstract][Full Text] [Related]
10. Sleep polygraphy in schizophrenia: methodological issues.
Thaker GK; Wagman AM; Tamminga CA
Biol Psychiatry; 1990 Aug; 28(3):240-6. PubMed ID: 1974153
[TBL] [Abstract][Full Text] [Related]
11. Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design.
Dixon L; Thaker G; Conley R; Ross D; Cascella N; Tamminga C
Schizophr Res; 1993 Oct; 10(3):267-71. PubMed ID: 8260445
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
[TBL] [Abstract][Full Text] [Related]
13. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
Nagase Y; Okubo Y; Toru M
Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
[TBL] [Abstract][Full Text] [Related]
14. Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients.
van Kammen DP; Kelley ME; Gurklis JA; Gilbertson MW; Yao JK; Condray R; Peters JL
Neuropsychopharmacology; 1996 Apr; 14(4):275-83. PubMed ID: 8924195
[TBL] [Abstract][Full Text] [Related]
15. P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.
Coburn KL; Shillcutt SD; Tucker KA; Estes KM; Brin FB; Merai P; Moore NC
Biol Psychiatry; 1998 Sep; 44(6):466-74. PubMed ID: 9777178
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
Singh H; Hunt JI; Vitiello B; Simpson GM
J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
[TBL] [Abstract][Full Text] [Related]
17. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
[TBL] [Abstract][Full Text] [Related]
18. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
Czobor P; Volavka J
J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
[TBL] [Abstract][Full Text] [Related]
19. [Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment].
Wolf MA; Bailly L; Diener JM; Martinet JP; Peretti S; Garneau Y
Encephale; 1991; 17(4):255-61. PubMed ID: 1683626
[TBL] [Abstract][Full Text] [Related]
20. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
